Autologous Matrix-Induced Chondrogenesis Market to Grow with Increasing Prevalence of Joint Disorders

It is a biological procedure used in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market to treat damaged articular cartilage. AMIC therapy is carried out in stages. After microfracture surgery, a bi-layer collagen I/III membrane is applied. With the goal of avoiding or delaying partial or total surgery for minor joint replacement (such as a knee replacement), it slows down cartilage deterioration. Chondral lesions in Grade III or IV, ranging in size from 2 cm2 to 8 cm2, are among the indications for AMIC.

Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/12271

In terms of value, the global autologous matrix-induced chondrogenesis (AMIC) Market is anticipated to grow at a CAGR of 8.6% during the forecast period. The value of the global market for autologous matrix-induced chondrogenesis is projected to be US$ 96.11 Million in 2016 and US$ 186.4 Million by the end of 2024.

The need for minimally invasive procedures has greatly increased in recent years. Patients are being encouraged to choose minimally invasive surgeries by benefits such less post-surgery complications and side effects, quicker patient recovery, and shorter hospital stays. As a result, the market for autologous matrix-induced chondrogenesis is anticipated to grow over the course of the forecast period due to the increased need for minimally invasive operations.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12271

Most of the countries have less or no reimbursement for autologous matrix-induced chondrogenesis products or procedures. Autologous matrix-induced chondrogenesis products or procedures are not reimbursed by several health insurance companies in Europe. There is no reimbursement in most of the developing countries such as India, Australia, and Brazil. Hence, lack of efficient reimbursement is likely to hamper the growth of the autologous matrix-induced chondrogenesis market during the forecast period.

Regional analysis : Autologous Matrix-induced Chondrogenesis Market

The global Autologous Matrix-Induced Chondrogenesis market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).

In terms of value, North America is estimated to be the dominant market for global Autologous Matrix-Induced Chondrogenesis market in 2016 and expected to witness a CAGR of 8.3% over the forecast period. APAC is estimated to be the fastest growing markets in terms of CAGR. PEG segment in the North America Autologous Matrix-Induced Chondrogenesis market is expected to register a CAGR of 11.3% over the forecast period.

Request For Customization @ https://www.persistencemarketresearch.com/request-customization/12271

Market Segmentation : Autologous Matrix-induced Chondrogenesis Market

• Autologous Matrix-induced Chondrogenesis Market By Material : Hyaluronic, Acid, Collagen, Polyethylene glycol (PEG), polylactic-co-glycolic acid (PGLA), Others
• Autologous Matrix-induced Chondrogenesis Market By Region : North America, Latin America, Europe, Asia pacific, MEA

Key market players

• Anika Therapeutics, Inc.,
• Arthro-Kinetics,
• Braun Melsungen AG,
• BioTissue AG,
• CartiHeal,
• Geistlich Pharma AG,
• JRI Orthopaedics Ltd.,
• Matricel GmbH,
• Smith & Nephew plc,
• Zimmer Biomet Holdings.

Some other Trending Reports -

Pressure Guidewires Market - https://www.persistencemarketresearch.com/market-research/pressure-guidewires-market.asp

Intra Operative Imaging Market - https://www.persistencemarketresearch.com/market-research/intra-operative-imaging-market.asp

About us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

This release was published on openPR.